In the dysbiotic gut of CRC patients, the abundance of rare Porphyromonas species, such as P. gingivalis and P. asaccharolytica, may promote CRC via butyrate-mediated activation of the PI3/Akt pathway (Okumura et al., 2021). Here, AKT1 is linked to colorectal carcinoma.